Evidence map›Paper›PMID 37006953›Full record

ArticleLeukemia research reports2023

Effective use of intensive treatment against multiple myeloma of recipient origin after allogeneic transplantation for acute myeloid leukemia.

Félicité de Charry, Johanna Konopacki, Sarah Bugier, Vincent Foissaud, Ivan Sloma, Jean-Valère Malfuson, Pierre Arnautou

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Leukemia research reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 96% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Félicité de CharryService d'hématologie, HIA Percy, Clamart, France.
Johanna KonopackiService d'hématologie, HIA Percy, Clamart, France.
Sarah BugierService de biologie médicale, HIA Percy, Clamart, France.
Vincent FoissaudService de biologie médicale, HIA Percy, Clamart, France.
Ivan SlomaDépartement d'hématologie et d'immunologie biologiques, Hôpital Henri Mondor, APHP, Créteil, France.
Jean-Valère MalfusonService d'hématologie, HIA Percy, Clamart, France.
Pierre ArnautouService d'hématologie, HIA Percy, Clamart, France.
Hôpital d'instruction des Armées Percy · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We describe here a 56-years -old woman cured in our institution for an acute myeloid leukemia (AML) and a monoclonal gammopathy of undetermined significance (MGUS). In order to treat AML, underwent allogeneic stem cell transplantation in second complete remission. Four years after transplant, MGUS evolved to multiple myeloma and was intensively treated with "autologous" transplant after successful mobilization. This report illustrates: (i) a lack of efficacy of graft versus myeloma effect in a patient probably cured of AML by graft versus leukaemia effect; (ii) the ability to mobilize peripheral blood stem cells in order to perform "autologous" transplantation after allogeneic transplantation.

Indexed as

Acute myeloid leukemiaAllogeneic hematopoietic stem cell transplantationAutologous hematopoietic stem cell transplantationMultiple myeloma

Identifiers

PMID37006953
PMCPMC10050635
OpenAlexW4327560450

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.